COMMUNIQUÉS West-GlobeNewswire

Aquinox Promotes Lloyd Mackenzie to Chief Operating Officer and Vice President, R&D Operations

15/12/2017 - 15:00

VANCOUVER, British Columbia, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ: AQXP ) today announced that Lloyd Mackenzie has been promoted, effective immediately, to the newly [...]

Progressive Care Reports Strong November Sales to Begin End of Year Rally

15/12/2017 - 14:59

MIAMI, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]

Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children

15/12/2017 - 14:30

TOKYO, LONDON and NOVATO, Calif., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), Kyowa Kirin International PLC (Kyowa Kirin International) and Ultragenyx Pharmaceutical Inc. (NASDAQ: [...]

Northern Vine Labs Expands Dealer’s License with Health Canada

15/12/2017 - 14:30

VICTORIA, B.C., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Northern Vine Labs (“Company”), a subsidiary of Emerald Health Therapeutics Inc. (“Emerald”) (TSXV:EMH) (OTCQX:EMHTF) and Abattis Bioceuticals Corp. (“Abattis”) (CSE:ATT [...]

Mersana Therapeutics Added to NASDAQ Biotechnology Index

15/12/2017 - 14:00

CAMBRIDGE, Mass., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ: MRSN ) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]

PolarityTE™ Announces Application of SkinTE™ on First Patients

15/12/2017 - 14:00

SALT LAKE CITY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ: COOL ) announced that human use of SkinTE™ is underway, and the product is now on patients, at multiple centers, within a variety of wound [...]

Tetraphase Pharmaceuticals Added to NASDAQ Biotechnology Index

15/12/2017 - 14:00

WATERTOWN, Mass., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant [...]

IBEX Reports First Quarter Fiscal 2018 Results

15/12/2017 - 14:00

MONTREAL, Dec. 15, 2017 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture:IBT) today reported its financial results for the quarter ended October 31, 2017. “Revenues and earnings for the [...]

Surgery Partners, Inc. Announces $50.0 Million Share Repurchase Program

15/12/2017 - 14:00

BRENTWOOD, Tenn., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that its Board of Directors has [...]

Extendicare Announces December 2017 Dividend of C$0.04 per Share

15/12/2017 - 14:00

MARKHAM, Ontario, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]

American Health Council Names Leslie Fletcher, BSN, RN, MEP-C to Nursing Board

15/12/2017 - 14:00

NEW YORK, Dec. 15, 2017 (GLOBE NEWSWIRE) -- The American Health Council has selected Leslie Fletcher, BSN, RN, MEP-C to join the Nursing Board. She has been chosen due to her impeccable work in the field of Aesthetics. [...]

Athenex Announces Initiation of an Oral Eribulin Investigational New Drug Development Program for Oncology Indications

15/12/2017 - 14:00

Athenex has developed a novel synthetic method for Eribulin with an excellent purity profile Athenex has developed an oral version of Eribulin based on the Orascovery program which showed good oral absorption in [...]

Endocyte Added to NASDAQ Biotechnology Index

15/12/2017 - 14:00

WEST LAFAYETTE, Ind., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that it has been [...]

Ozempic® (semaglutide) recommended for approval by the European regulatory authorities

15/12/2017 - 13:13

Bagsværd, Denmark, 15 December 2017 - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has adopted a positive opinion, recommending [...]

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease

15/12/2017 - 13:12

PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease First allogeneic [...]

Takeda et TiGenix annoncent que le Cx601 (darvadstrocel) a reçu la décision favorable du CHMP dans le traitement des fistules périanales complexes de la maladie de Crohn

15/12/2017 - 13:12

COMMUNIQUE DE PRESSE INFORMATION REGLEMENTEE CONNAISSANCE PREALABLE Takeda et TiGenix annoncent que le Cx601 (darvadstrocel) a reçu la décision favorable du CHMP dans le traitement des fistules périanales complexes de [...]

Sanofi: FDA lifts clinical hold on fitusiran

15/12/2017 - 13:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) FDA lifts clinical hold on fitusiran Clinical trial dosing to resume around year-end 2017 Paris and Cambridge, Mass. - December 15, 2017 - Sanofi Genzyme , the [...]

Sanofi : La FDA lève la suspension des essais cliniques consacrés au fitusiran

15/12/2017 - 13:01

Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) La FDA lève la suspension des essais cliniques consacrés au fitusiran L'administration de ce médicament dans le cadre des essais cliniques qui lui sont [...]

Ohr Pharmaceutical Reports Fiscal Year 2017 Financial Results

15/12/2017 - 13:00

Management to Host a Conference Call and Webcast at 8:30 a.m. Eastern Time Today NEW YORK, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP ), a clinical-stage pharmaceutical company developing [...]